Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2003 Jan;81(1):20-31.
doi: 10.1007/s00109-002-0397-4. Epub 2002 Dec 14.

The role of VEGF in normal and neoplastic hematopoiesis

Hans-Peter Gerber  1 , Napoleone Ferrara
Affiliations
Review

The role of VEGF in normal and neoplastic hematopoiesis

Hans-Peter Gerber et al. J Mol Med (Berl). 2003 Jan.

Abstract

VEGF is a secreted growth factor that mediates its biological effects by binding to two transmembrane tyrosine kinase receptors, VEGFR-1 and VEGFR-2. The VEGF/receptor signaling system is involved in the regulation of two fundamental processes in vertebrates: the formation of blood vessels (angiogenesis) and of blood cells (hematopoiesis). Hematopoietic stem cells, capable of giving rise to all blood cell lineages, are often found in clusters with endothelial cells, the key cell type involved in the formation of blood vessels. Despite such proximity of VEGF-responsive cells, hematopoiesis occurs independently of neoangiogenesis in the adult bone marrow, suggesting that VEGF regulates the two processes by different mechanisms. In support of this hypothesis, the recently identified autocrine loop by which VEGF may control hematopoietic stem cell survival and repopulation, is fundamentally different from its paracrine effects regulating angiogenesis. Furthermore, coexpression of VEGF and its receptors, the prerequisite for autocrine loops, is frequently found in lymphomas and myelomas, suggesting that autocrine loops also play a role in hematological malignancies. Several therapeutic strategies blocking VEGF or VEGF-induced signaling are currently being investigated for the treatment of neoplastic diseases. They differ in their potential to interfere with the autocrine or paracrine effector functions of VEGF during angiogenesis, hematopoiesis, and tumor cell proliferation, properties which may ultimately determine their therapeutic potential.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Cell. 1998 Mar 20;92(6):735-45 - PubMed
    1. Nature. 2002 Jun 27;417(6892):954-8 - PubMed
    1. Br J Haematol. 1998 Dec;103(4):969-79 - PubMed
    1. J Biol Chem. 2001 Feb 2;276(5):3222-30 - PubMed
    1. Nature. 1995 Jul 6;376(6535):66-70 - PubMed

MeSH terms

Substances

LinkOut - more resources